Inactive Instrument
Argos Therapeutics Inc Share Price Nasdaq
Stocks
US0402211033
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 284K 265K 240K 453K 30.72M 456K 3.18M 1.24M 15.62M 1.19M 1.17M 50.23M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 4.1M 3.82M 3.47M 6.54M 444M 6.59M 45.93M 17.94M 226M 17.21M 16.84M 725M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +0.46% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +1,231.29% | - | - | 567K | |
| +2.70% | +2.73% | +40.91% | +110.31% | 1,060B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 623B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 480B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 352B | |
| +2.92% | +3.12% | +24.78% | +45.10% | 345B | |
| +2.42% | +0.05% | +14.13% | +35.80% | 274B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 249B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 223B | |
| +1.82% | -1.48% | +25.75% | +96.48% | 182B | |
| Average | +1.36% | -0.48% | +28.56% | +59.87% | 420.89B | |
| Weighted average by Cap. | +0.81% | +0.04% | +32.00% | +70.72% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 845K 788K 716K 1.35M 91.46M 1.36M 9.47M 3.7M 46.51M 3.55M 3.47M 150M | 1.9M 1.7M 1.58M 1.44M 2.71M 184M 2.73M 19.03M 7.43M 93.44M 7.13M 6.98M 300M |
| Net income | -53.03M -47.38M -44.2M -40.15M -75.62M -5.13B -76.19M -531M -208M -2.61B -199M -195M -8.39B | -40.58M -36.26M -33.83M -30.72M -57.87M -3.93B -58.3M -406M -159M -2B -152M -149M -6.42B |
| Net Debt | -13.11M -11.71M -10.93M -9.93M -18.69M -1.27B -18.83M -131M -51.3M -645M -49.21M -48.15M -2.07B | 4.27M 3.81M 3.56M 3.23M 6.09M 413M 6.13M 42.75M 16.7M 210M 16.02M 15.67M 675M |
Employees
-
Sector
Pharmaceuticals
